Skip to main content
OpenTrials

Clinical trial condition

Advanced Cancer

Explore clinical trials studying Advanced Cancer. Study availability and eligibility vary by location and protocol.

455 public trials 86 recruiting studies
Refine in advanced search Browse all conditions

Advanced Cancer trial results

Completed

STAMP+CBT mHealth for Cancer Pain

NCT05403801

Conditions
Active Cancer, Active Cancer Treatment, Advanced Cancer, +2 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Dana-Farber at Merrimack Valley Methuen, Massachusetts, United States
  • Dana-Farber at Londonderry Londonderry, New Hampshire, United States
View Trial Details
Completed

A Study of Bispecific Antibody MCLA-145 in Patients With Advanced or Metastatic Malignancies

NCT03922204

Conditions
Advanced Cancer, B-cell Lymphoma, Adult, Hemic and Lymphatic Diseases, +10 more
Locations
  • Moores Cancer Centre La Jolla, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • University Hospital Antwerp Antwerp, Edegem, Belgium
View Trial Details
Completed

The PediQUEST Response Intervention Study

NCT03408314

Conditions
Advanced Cancer
Locations
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
View Trial Details
Completed

A Dose Escalation and Expansion Study of ASP4132 to Subjects With Advanced Refractory Tumors and Lymphoma

NCT02383368

Conditions
Advanced Cancer, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations
  • Site US10001 New Haven, Connecticut, United States
  • Site US10004 Chicago, Illinois, United States
  • Site US10002 Rochester, Minnesota, United States
  • Site US10003 Houston, Texas, United States
View Trial Details
Completed

A Study of the Safety and PK of PCS6422 (Eniluracil) with Capecitabine in Patients with Advanced, Refractory GI Tract Tumors

NCT04861987

Conditions
Advanced Cancer, Digestive System Diseases, Digestive System Neoplasms, +8 more
Locations
  • Processa Clinical Site Omaha, Nebraska, United States
  • Processa Clinical Site New Brunswick, New Jersey, United States
  • Processa Clinical Site Santa Fe, New Mexico, United States
  • Processa Clinical Site New York, United States
View Trial Details
Completed

A Study of BMS-986406 as Monotherapy and Combination Therapies in Participants With Advanced Tumors

NCT05298592

Conditions
Advanced Cancer
Locations
  • Local Institution - 0021 Birmingham, Alabama, United States
  • University California San Diego Moores Cancer Center La Jolla, California, United States
  • The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate Los Angeles, California, United States
  • UCLA Health Los Angeles, California, United States
View all 29 locations
View Trial Details

Related conditions